The pharmaceutical industry's growth prospects appear promising due to factors including the adoption of advanced technologies, increased investment in research and development (R&D), the prevalence of chronic diseases, a rapidly aging population, and the development of drugs for rare conditions.
Therefore, it could be wise to consider buying fundamentally strong pharma stocks Perrigo Company plc (PRGO), ACADIA Pharmaceuticals Inc. (ACAD), and Pacira BioSciences, Inc. (PCRX).
